In recent years,with the development of medical technology,the detection rate of cancer is getting higher and higher,and the population of patients is getting younger.Many studies have begun to study the early diagnos...In recent years,with the development of medical technology,the detection rate of cancer is getting higher and higher,and the population of patients is getting younger.Many studies have begun to study the early diagnosis,prognostic monitoring markers and pathogenesis of cancer.In recent years,with the development of bioinformatics technology,lncRNA have gradually attracted the attention of researchers.More and more studies have shown that lncRNA are responsible for various biological functions in the process of cancer progression.lncRNA MAFG-AS1 has been shown to be associated with multiple cancers,function as an oncogene,and is significantly associated with poor clinical features and prognosis.This article reviews the research progress of lncRNA MAFG-AS1 in cancer,hoping to provide some help for the future clinical diagnosis and treatment of cancer.展开更多
目的探讨LncRNA-MAFG-AS1在结直肠癌中的表达及临床意义。方法选取我院行手术切除的结直肠癌组织及对应的癌旁正常组织各80例,应用定量即时聚合酶链锁反应(quantitative real time polymerase chain reaction,qRT-PCR)检测结直肠癌组织...目的探讨LncRNA-MAFG-AS1在结直肠癌中的表达及临床意义。方法选取我院行手术切除的结直肠癌组织及对应的癌旁正常组织各80例,应用定量即时聚合酶链锁反应(quantitative real time polymerase chain reaction,qRT-PCR)检测结直肠癌组织及癌旁正常组织中LncRNA-MAFG-AS1的表达水平,并分析其与结直肠癌临床病理特征之间的关系,所有患者随访截止日期到2019年12月31日,应用Kaplan-Meier(K-M)法进行生存分析,采用Cox回归模型分析结直肠癌预后的危险因素。结果结直肠癌组织中LncRNA-MAFG-AS1相对表达量为2.398±0.214,高于癌旁正常组织的1.032±0.132,差异有统计学意义(P<0.05)。当患者TNM分期更高、中高分化及存在淋巴结转移和远期转移时,LncRNA-MAFG-AS1过表达(P<0.05)。K-M生存分析显示高表达患者无进展生存时间(progression-free survival,PFS)为(20.36±3.21)个月,低表达患者为(29.71±4.23)个月;高表达患者的总生存时间(overall survival,OS)为(38.69±6.24)个月,低高表达患者为(54.26±5.14)个月;两组患者的PFS和OS差异有统计学意义(P<0.05)。Cox多因素回归分析显示,TNM分期更高、中高分化及存在淋巴结转移、远期转移以及LncRNA-MAFG-AS1高表达是影响结直肠癌预后的独立危险因素。结论LncRNA-MAFG-AS1在结直肠癌组织中呈高表达,且与结直肠癌患者分化程度、TNM分期、淋巴结和远期转移有关,是影响结直肠癌患者预后的独立风险因素。展开更多
基金Hainan Province Higher Education Science Research Project(No.Hnky2020ZD-15)。
文摘In recent years,with the development of medical technology,the detection rate of cancer is getting higher and higher,and the population of patients is getting younger.Many studies have begun to study the early diagnosis,prognostic monitoring markers and pathogenesis of cancer.In recent years,with the development of bioinformatics technology,lncRNA have gradually attracted the attention of researchers.More and more studies have shown that lncRNA are responsible for various biological functions in the process of cancer progression.lncRNA MAFG-AS1 has been shown to be associated with multiple cancers,function as an oncogene,and is significantly associated with poor clinical features and prognosis.This article reviews the research progress of lncRNA MAFG-AS1 in cancer,hoping to provide some help for the future clinical diagnosis and treatment of cancer.
文摘目的探讨LncRNA-MAFG-AS1在结直肠癌中的表达及临床意义。方法选取我院行手术切除的结直肠癌组织及对应的癌旁正常组织各80例,应用定量即时聚合酶链锁反应(quantitative real time polymerase chain reaction,qRT-PCR)检测结直肠癌组织及癌旁正常组织中LncRNA-MAFG-AS1的表达水平,并分析其与结直肠癌临床病理特征之间的关系,所有患者随访截止日期到2019年12月31日,应用Kaplan-Meier(K-M)法进行生存分析,采用Cox回归模型分析结直肠癌预后的危险因素。结果结直肠癌组织中LncRNA-MAFG-AS1相对表达量为2.398±0.214,高于癌旁正常组织的1.032±0.132,差异有统计学意义(P<0.05)。当患者TNM分期更高、中高分化及存在淋巴结转移和远期转移时,LncRNA-MAFG-AS1过表达(P<0.05)。K-M生存分析显示高表达患者无进展生存时间(progression-free survival,PFS)为(20.36±3.21)个月,低表达患者为(29.71±4.23)个月;高表达患者的总生存时间(overall survival,OS)为(38.69±6.24)个月,低高表达患者为(54.26±5.14)个月;两组患者的PFS和OS差异有统计学意义(P<0.05)。Cox多因素回归分析显示,TNM分期更高、中高分化及存在淋巴结转移、远期转移以及LncRNA-MAFG-AS1高表达是影响结直肠癌预后的独立危险因素。结论LncRNA-MAFG-AS1在结直肠癌组织中呈高表达,且与结直肠癌患者分化程度、TNM分期、淋巴结和远期转移有关,是影响结直肠癌患者预后的独立风险因素。
基金This work was supported by the National Natural Science Foundation of China(81874137)the Outstanding Youth Foundation of Hunan Province(2018JJ1047)+4 种基金the Huxiang Young Talent Project(2016RS3022)the Hunan Province Science and Technology Talent Promotion Project(2019TJ-Q10)the Project of Scientific Research Plan of Health and Family Planning Commission of Hunan Province(c20180476)the Fundamental Research Funds for the Central South University(2018zzts938)the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hosipital of Central South University(ZC060001 and YX202007).
